Startup Profile

Invatin technologies

Invatin developed the Synaxis , one of a kind permanent stroke prevention device.

Location

Katsrin

Funding Stage

Round A

Company Vertical

BioTech
Last Modified: December 2, 2025

Description

The SYNAXIS stent is a groundbreaking Intravascular Stroke Prevention Device (SPD) that directly divert blood clots from the cranial brunches and prevent stroke. The system maintain its high short-term and long-term potency while conserving the blood pressure and flow patterns. The SYNAXIS system is composed of a designated aortic arch implant equipped with a build in filtering unit , both are delivered in a minimally invasive manner using a state of the art delivery system that ensures accurate deployment and positioning. The SYNAXIS catheter, using a standard procedure is inserted in to the aortic arch by a cardiologist or invasive radiologists . The system dedicated filtering unit is composed of cutting edge materials that prevents neointima proliferation and thrombosis. The SYNAXIS is a special device designed to prevents stroke with long time patency. Synaxis will prevent the need for OACs treatment Patients can return to daily activity without the risk of life threatening bleeding. No need for frequent blood tests. Prevents OACs-related complications and morbidity Enhanced patient safety & treatment compliance Improved quality of life

Nortech Startup COnnector

Year founded

2016

Social Networks

Location

Auto Scroll Page